9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Canadian Newspaper Coverage of the A/H1N1 Vaccine Program

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          The A/H1N1 mass vaccination program in Canada garnered considerable attention from the media, including extensive newspaper coverage. Media reports have been shown to influence the public’s health care decisions, including vaccination choices. We analyzed Canadian newspapers’ portrayal of the A/H1N1 vaccine including mention of risks and benefits of the vaccine and whether the article supported, questioned or was neutral about the vaccine.

          Methods

          We compiled a data set of Canadian newspaper articles (N=234) and conducted a frequency content analysis to examine discussion and/or mention of evidence concerning vaccination, risks of the A/H1N1 virus and the vaccine, and tone of article in regards to the vaccination program in Canada.

          Results

          Reasons for getting vaccinated appeared in 71.8% of the articles, whereas only 18.4% provided reasons against getting vaccinated. Discussion of evidence to support claims for or against getting vaccinated appeared in only 27.8% and 6.8% of the articles, respectively. Risks associated with contracting the A/H1N1 virus were discussed in 49.6% of the articles and risks of the A/H1N1 vaccine were discussed in 12.4% of the articles.

          Conclusion

          Newspaper coverage in Canada was largely supportive of the A/H1N1 mass vaccination program. However, serious risks associated with contracting the A/H1N1 virus were also frequently discussed in the print media. The news articles rarely presented direct evidence to support statements that the vaccine was safe, effective and properly tested. Known risks (such as potential allergic reactions and flu-like side effects) of the vaccine were rarely reported. The relationship between media portrayals and vaccine uptake warrants further research.

          Résumé

          Objectifs

          Le programme de vaccination de masse contre le virus A/H1N1 au Canada a fait l’objet d’une couverture médiatique considérable, y compris dans les journaux. Il est démontré que ces reportages influencent les décisions du public à l’égard de la santé, notamment les choix concernant la vaccination. Nous avons analysé la représentation du vaccin anti-A/H1N1 dans les journaux canadiens, à savoir: la mention des risques et des avantages du vaccin et si l’article était pour ou contre le vaccin ou s’il était neutre à ce sujet.

          Méthode

          Nous avons compilé un jeu de données composé d’articles de journaux canadiens (N=234) et effectué une analyse de fréquence de contenu pour examiner la discussion et/ou la mention des preuves liées à la vaccination, les risques du virus A/H1N1 et du vaccin, et le ton de l’article à l’égard du programme de vaccination au Canada.

          Résultats

          Les raisons de se faire vacciner étaient citées dans 71,8 % des articles, tandis que seulement 18,4 % citaient des raisons de ne pas se faire vacciner. Une discussion des preuves à l’appui des allégations pour ou contre le vaccin ne figurait que dans 27,8 % et dans 6,8 % des articles, respectivement. Les risques associés au virus A/H1N1 étaient discutés dans 49,6 % des articles, et les risques du vaccin étaient discutés dans 12,4 % des articles.

          Conclusion

          Les journaux canadiens étaient en grande partie favorables au programme de vaccination de masse contre le virus A/H1N1. Les risques graves associés au virus étaient fréquemment cités dans la presse écrite. Les articles de fond ont cependant rarement présenté des preuves directes à l’appui des déclarations selon lesquelles le vaccin était sûr, efficace et dûment testé. Les risques connus du vaccin (comme les réactions allergiques possibles et les effets secondaires pseudo-grippaux) ont rarement été mentionnés. Le lien entre la représentation du programme dans les médias et l’acceptation du vaccin devrait faire l’objet d’une étude plus poussée.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: not found
          • Article: not found

          Science and society. Framing Science.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Guillain-Barré syndrome following influenza vaccination.

            An unexplained increase in the risk of Guillain-Barre syndrome (GBS) occurred among recipients of the swine influenza vaccine in 1976-1977. Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990. To evaluate trends of reports to VAERS of GBS following influenza vaccination in adults. VAERS is the US national spontaneous reporting system for adverse events following vaccination. Reports of GBS in persons 18 years or older following influenza vaccination were evaluated for each influenza season from July 1, 1990, through June 30, 2003. The number of people vaccinated was estimated from the National Health Interview Survey and US census data. Beginning in 1994, active follow-up was conducted to verify GBS diagnosis and obtain other clinical details. Reporting rates of GBS following influenza vaccination over time. From July 1990 through June 2003, VAERS received 501 reports of GBS following influenza vaccination in adults. The median onset interval (13 days) was longer than that of non-GBS reports of adverse events after influenza vaccine (1 day) (P<.001). The annual reporting rate decreased 4-fold from a high of 0.17 per 100,000 vaccinees in 1993-1994 to 0.04 in 2002-2003 (P<.001). A GBS diagnosis was confirmed in 82% of reports. Preceding illness within 4 weeks of vaccination was identified in 24% of reported cases. From 1990 to 2003, VAERS reporting rates of GBS after influenza vaccination decreased. The long onset interval and low prevalence of other preexisting illnesses are consistent with a possible causal association between GBS and influenza vaccine. These findings require additional research, which can lead to a fuller understanding of the causes of GBS and its possible relationship with influenza vaccine.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Perceived seriousness of seasonal and A(H1N1) influenzas, attitudes toward vaccination, and vaccine uptake among U.S. adults: does the source of information matter?

              We estimated uptake of seasonal and 2009 influenza A(H1N1) vaccine among U.S. adults and assessed their perceptions of the seriousness of both types of influenza and corresponding attitudes toward vaccination during the 2009-2010 influenza season. We further documented how vaccine uptake and attitudes varied by main information source used in vaccination decisions. We analyzed nationally representative data from U.S. adults age 18 and older (N=3,917) who completed an influenza vaccination survey between March 4th and March 24th, 2010. 2009 influenza A(H1N1) vaccine uptake was considerably lower than seasonal vaccine uptake. While 2009 influenza A(H1N1) was perceived to be more serious than seasonal influenza, the pandemic vaccine was perceived to be less safe than the seasonal vaccine. Vaccine uptake and attitudes displayed large variation between adults who relied on different information sources for making their vaccination decisions. The information launched during the response to the 2009 pandemic appear to have generated higher levels of concern about pandemic than seasonal influenza, but did not appear to reassure adults of the safety and value of the pandemic vaccine. Differences in perceived vaccination safety may be an important factor for explaining the lower uptake of pandemic relative to seasonal vaccine. Copyright 2010 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                780-492-8358 , 780-492-9575 , tcaulfld@law.ualberta.ca
                Journal
                Can J Public Health
                Can J Public Health
                Canadian Journal of Public Health = Revue Canadienne de Santé Publique
                Springer International Publishing (Cham )
                0008-4263
                1920-7476
                1 May 2011
                May 2011
                : 102
                : 3
                : 200-203
                Affiliations
                [111 ]GRID grid.17089.37, Health Law Institute, , University of Alberta, ; AB T6G 2H5 Edmonton, Canada
                [211 ]GRID grid.143640.4, ISNI 0000 0004 1936 9465, Faculty of Law, , University of Victoria, ; Victoria, BC Canada
                [311 ]GRID grid.17089.37, Alberta Heritage Foundation for Medical Research, , University of Alberta, ; Edmonton, AB Canada
                [411 ]GRID grid.17089.37, Faculty of Law and School of Public Health, , University of Alberta, ; Edmonton, AB Canada
                Article
                BF03404896
                10.1007/BF03404896
                6973664
                21714319
                de9c19ae-d566-4985-86c0-6353042aa6d0
                © The Canadian Public Health Association 2011
                History
                : 31 August 2010
                : 4 December 2010
                Categories
                Quantitative Research
                Custom metadata
                © The Canadian Public Health Association 2011

                journaux,vaccins antigrippaux,canada,newspapers,influenza vaccines

                Comments

                Comment on this article